Clinical TrialID 7220

The Efficacy and Safety of Caffeic Acid for Esophageal Cancer

NCT03070262

Esophagus Cancer

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
7220
Evidence Id
7220
Core Evidence Id
7220
Source Clinical Trial Id
7210
Herb2 Clinical Trial Id
HBCT007210
Nct Id
NCT03070262
Title
The Efficacy and Safety of Caffeic Acid for Esophageal Cancer
Status
Phase
Phase 3
Study Result
No
Study Condition
Esophagus Cancer
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
DRUG: CA|DRUG: placebo group
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Quadruple
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
300
Outcome Measure
overall survival (OS), The percentage of 1 year overall survival (OS) after random allocation. The follow-up will be done every 3 months through phone call, investigator visiting, and medical recording review., 1 year
Sponsor Collaborator
The First Affiliated Hospital of Henan University of Science and Technology|Anyang Tumor Hospital|150th Hospital of PLA
Funded By
OTHER
Location
The Clinical Medical College, The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, Henan, 471003, China
Other Id
GiCAEC-LY001
Start Date
2017-01
Primary Completion Date
2020-12
Completion Date
2021-12
First Posted
2017-03-03
Results First Posted
Last Update Posted
2020-11-27
Study Document
Study Url
https://clinicaltrials.gov/study/NCT03070262
Title Cn
Title En
The Efficacy and Safety of Caffeic Acid for Esophageal Cancer
Bilingual Status
semi_complete